Latest news with #MotivePartners
Yahoo
02-06-2025
- Business
- Yahoo
AI-built startups could fuel increase in venture capital ‘zombie' funds
Beware of zombies. That's the message from some venture capital executives who predict that AI will drive down the cost and time startup founders need to build businesses—but also increase the number of 'zombies.' These are VCs firms who find little demand for their services, and are left to wander the tech landscape without fresh capital or new investments. Due to AI, founders will become so efficient building companies that they will no longer need to raise multiple rounds of capital, says Sam Tidswell-Norrish, who, in December, left private equity firm Motive Partners, and has since launched professional community platform OPUS. Tidswell-Norrish predicts that, over the next five years, founders will likely collect enough capital in one round and then achieve profitability. This means VCs will end up competing with each other for fewer allocations and will have to go downstream to find companies, he said. Ben Savage, a partner at Clocktower Ventures, doesn't agree. Savage thinks AI will likely spur more ideas that cause founders to create more startups and possibly reinvent more segments of the economy. Matt Harris, a partner with Bain Capital Ventures, pointed to the cloud computing and SaaS boom of the last decade, which some thought would hurt VCs. Harris thinks the current AI revolution could lead to more VC allocations. For venture capitalists, AI could threaten their position or provide an opportunity, said OPUS's Tidswell-Norrish. Many firms raised capital, and were investing, during the bull market of 2021 when startup valuations were at a high. Venture funds often take years to sell their stakes, so firms could build their profile and raise multiple funds before having to return capital, he said. The venture industry is currently in a downturn with only the top tier and differentiated funds continuing to raise money, he said. There are already a number of VC firms that aren't investing further and just running 'their existing fund lifespans down passively,' Tidswell-Norrish said. OPUS's Tidswell-Norrish thinks AI will create a power shift in favor of the founders, who will need less capital. He expects many VC firms will consolidate or just collapse over the next decade. Because the firms have funds with a 10-year life cycle, many will 'take a long time to die,' he said. The number of U.S. zombie venture firms has increased. At the beginning of 2025, there were 574 U.S. zombies, or firms that have raised a fund in the prior six years but have no known investments since late December 2023, according to data from research firm PitchBook. This compares to the end of 2021 when there were 382 U.S. zombies that had raised a fund since 2016 but had no known investments since the end of 2020. Many of the VCs who spoke to Fortune agree there will be a weeding out of the venture capital sector but it's not necessarily because of AI. The IPO market has been shut for nearly four years while mergers have crawled, making it hard for venture funds to sell their deals. Funds that started in 2020, invested in 2021— a record time period for deals when companies were selling for high multiples—and still don't have liquidity in 2025, will have a hard time raising a second pool in 2026 and 2027, said Peter Walker, head of insights at equity management platform Carta. 'A lot of funds don't have great performance metrics right now. If your last fund didn't do very well, it's a much tougher climate to raise new funds,' he said. Clocktower's Savage said there are always 'over performing and underperforming' venture firms but it's still too early to determine the impact of 2021 investing on fund performance. 'There's a lot of different forces at play in the capital formation of venture capital firms,' Savage said. Firms that survive will be VCs with a 'differentiated means to create value,' said OPUS's Tidswell-Norrish. This is more than the typical VC strategy of just providing capital but offering unique strategies, or expertise or networks that a founder can use to boost their startup's growth or chance for success. 'Ninety percent of VCs do not have real capability beyond their team supporting,' he said. The lack of distribution is one reason why Tidswell-Norrish launched OPUS, which aims to provide networking connections for early-stage entrepreneurs and founders. In 2026, OPUS is expected to begin marketing for its first fund, which is targeting $20 million to $40 million, a person familiar with the situation said. 'It's a huge existential shift. We will see a reckoning,' Tidswell-Norrish added. This story was originally featured on
Yahoo
27-05-2025
- Business
- Yahoo
AI-scaled startups are poised to disrupt venture capital—but VCs say don't count them out just yet
Venture capital is about disrupting established business models, but lately it is VCs themselves who are facing disruption. The reason is AI, which is driving down the time and cost to build a startup, and has led some to predict a major shakeout is coming for venture capital firms. Ten years ago, entrepreneurs looking to build a dating app would have needed millions of dollars, and years of development before they could launch the business, said Sam Tidswell-Norrish, a senior founding member of Motive Partners, who left the private equity firm in December. He says that, today, those same founders can get on a Zoom call with their team and build the app out by the end of the day. 'Capital intensive businesses don't exist anymore,' said Tidswell-Norrish, who has launched OPUS, a professional community platform. Ben Savage, a partner at Clocktower Ventures, agrees AI is changing the VC industry. 'Companies are getting to scale in product and revenue with much smaller headcounts than we've seen before,' Savage said. 'For sure, there's going to be more efficient companies built.' Jay Reinemann, general partner of Propel Venture Partners, agrees that AI will make building a startup more efficient, although he thinks building an app in 'less than a day' is an overstatement, and might only be true for very simple business models. 'We see AI-powered seed stage founders building faster and getting to product market fit quicker,' Reinemann said. This AI-induced efficiency means companies will no longer need to raise multiple rounds of capital, said Tidswell-Norrish of OPUS. Instead, over the next five years, founders will likely collect enough capital in one round and then achieve profitability, he said. This means VCs will end up competing with each other for fewer allocations and will have to go downstream to find companies, Tidswell-Norrish said. 'Getting to the companies earlier will be more important. VCs will have to start playing in the pre-seed and seed space,' he said. These changes are poised to make the venture capital world more competitive but, in a twist of the old Mark Twain quote, reports of venture capital's death may be greatly exaggerated. Clocktower's Savage, for instance, thinks AI will likely spur more ideas that cause founders to create more startups and possibly reinvent more segments of the economy. These businesses will need more capital, which will come from VCs, Savage said. 'Venture capital is the rocket fuel for innovation,' Savage said. 'The U.S. tech industry, funded by venture capital, is the greatest source of innovation in human history.' Matt Harris, a partner with Bain Capital Ventures, also doesn't think the AI revolution will lead to fewer VC allocations. He pointed to the huge fundraising rounds of AI companies, which are now a majority of the venture asset class. In April, OpenAI raised $40 billion at a $300 billion valuation, while Anthropic the month before collected $3.5 billion at a $61.5 billion valuation. 'The trend is in the other direction,' Harris said. Predictions of venture's demise due to AI are 'nonsense,' Harris said. He saw a similar trend occur over a decade ago when the advent of cloud computing and SaaS helped founders develop companies more cheaply and easily. Some believed this would hurt VCs. 'Instead, it led to the SaaS boom,' Harris said. More than 9,000 SaaS companies were started between 2010 and 2017, considered the core Saas boom years, according to Exploding Topics. AI should make it easier for founders to build and copy products, which will lead to lots of competition because 'tons of companies will be doing the same thing,' said Peter Walker, head of insights at equity management platform Carta. Startups will need capital to spend on distribution, including marketing and advertising so they can stand out, Walker said. 'We don't hear from too many VCs worrying that AI will ruin venture capital,' he said. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-03-2025
- Business
- Yahoo
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
NEW YORK, March 10, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025. "Bridget has a proven track record of growing global software businesses, and we are pleased to welcome her to our Board," said Ramy Farid, Ph.D., chief executive officer of Schrödinger. "Bridget's leadership experience overseeing strategic initiatives at global technology companies, including IBM, will be valuable to Schrödinger as we continue to advance our computational platform and are positioned for long-term success." Ms. van Kralingen brings more than 35 years of experience leading and growing global technology solution and software businesses and is currently a senior partner at Motive Partners, an investment firm focused on technology-enabled companies. Prior to Motive Partners, Ms. van Kralingen spent nearly 18 years in a variety of chief executive roles at IBM. She most recently served as chief executive/senior vice president of IBM Global Markets, where she was responsible for IBM's $80 billion revenue and profit, leading strategy, execution, offerings, go to market, field operations, delivery and client satisfaction across all geographic markets and global industries. Prior to that, she was chief executive of IBM's Industry Platforms software division. Before joining IBM in 2004, Ms. van Kralingen served as a managing partner at Deloitte Consulting, where she worked for 15 years. Ms. van Kralingen holds positions on several boards, including Teradyne, IEX Group, Travelers Companies, and Discovery Limited. "I'm honored to join Schrödinger's Board of Directors at this exciting time in the company's evolution," said Bridget van Kralingen. "Schrödinger is at the forefront of revolutionizing medicines and materials discovery, and I look forward to contributing to the company's continued growth and success." About SchrödingerSchrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit follow us on LinkedIn and Instagram, or visit our blog, Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those regarding our expectations about the benefits of our computational platform, and our strategic plans to accelerate the growth of our software licensing business and advance our collaborative and proprietary drug discovery programs. Statements including words such as "aim," "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "goal," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," "would" and statements in the future tense are forward-looking statements. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including the demand for our software platform, our ability to further develop our computational platform, the ability to retain and hire key personnel and other risks detailed under the caption "Risk Factors" and elsewhere in our Securities and Exchange Commission filings and reports, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on February 26, 2025, as well as future filings and reports by us. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise. View source version on Contacts Matthew Luchini (Investors) 917-719-0636 Allie Nicodemo (Media) 617-356-2325 Sign in to access your portfolio
Associated Press
10-03-2025
- Business
- Associated Press
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
NEW YORK--(BUSINESS WIRE)--Mar 10, 2025-- Schrödinger, Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025. This press release features multimedia. View the full release here: Bridget van Kralingen was appointed to Schrödinger's Board of Directors in March 2025. (Photo: Business Wire) 'Bridget has a proven track record of growing global software businesses, and we are pleased to welcome her to our Board,' said Ramy Farid, Ph.D., chief executive officer of Schrödinger. 'Bridget's leadership experience overseeing strategic initiatives at global technology companies, including IBM, will be valuable to Schrödinger as we continue to advance our computational platform and are positioned for long-term success.' Ms. van Kralingen brings more than 35 years of experience leading and growing global technology solution and software businesses and is currently a senior partner at Motive Partners, an investment firm focused on technology-enabled companies. Prior to Motive Partners, Ms. van Kralingen spent nearly 18 years in a variety of chief executive roles at IBM. She most recently served as chief executive/senior vice president of IBM Global Markets, where she was responsible for IBM's $80 billion revenue and profit, leading strategy, execution, offerings, go to market, field operations, delivery and client satisfaction across all geographic markets and global industries. Prior to that, she was chief executive of IBM's Industry Platforms software division. Before joining IBM in 2004, Ms. van Kralingen served as a managing partner at Deloitte Consulting, where she worked for 15 years. Ms. van Kralingen holds positions on several boards, including Teradyne, IEX Group, Travelers Companies, and Discovery Limited. 'I'm honored to join Schrödinger's Board of Directors at this exciting time in the company's evolution,' said Bridget van Kralingen. 'Schrödinger is at the forefront of revolutionizing medicines and materials discovery, and I look forward to contributing to the company's continued growth and success.' About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit follow us on LinkedIn and Instagram, or visit our blog, Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those regarding our expectations about the benefits of our computational platform, and our strategic plans to accelerate the growth of our software licensing business and advance our collaborative and proprietary drug discovery programs. Statements including words such as 'aim,' 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'goal,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and statements in the future tense are forward-looking statements. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including the demand for our software platform, our ability to further develop our computational platform, the ability to retain and hire key personnel and other risks detailed under the caption 'Risk Factors' and elsewhere in our Securities and Exchange Commission filings and reports, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on February 26, 2025, as well as future filings and reports by us. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise. This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those regarding our expectations about the benefits of our computational platform, and our strategic plans to accelerate the growth of our software licensing business and advance our collaborative and proprietary drug discovery programs. Statements including words such as 'aim,' 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'goal,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and statements in the future tense are forward-looking statements. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including the demand for our software platform, our ability to further develop our computational platform, the ability to retain and hire key personnel and other risks detailed under the caption 'Risk Factors' and elsewhere in our Securities and Exchange Commission filings and reports, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on February 26, 2025, as well as future filings and reports by us. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise. 617-356-2325 SOURCE: Schrödinger Copyright Business Wire 2025. PUB: 03/10/2025 08:30 AM/DISC: 03/10/2025 08:30 AM
